SpringWorks Therapeutics Inc (SWTX)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current SWTX market cap is 3.1B. The company's latest EPS is USD -4.3882 and P/E is -9.54.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 5.45M | 21.01M |
| Operating Income | -78.98M | -83.75M | -85.02M | -100.3M | -94.96M |
| Net Income | -73.42M | -77.93M | -79.44M | -94.32M | -87.39M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 35M | 0 | 0 | 5.45M |
| Operating Income | -61.85M | -46.93M | -174.46M | -283.56M | -348.05M |
| Net Income | -50.58M | -45.57M | -173.91M | -277.42M | -325.1M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 569.2M | 517.33M | 467.65M | 725.79M | 656.83M |
| Total Liabilities | 62.27M | 65.89M | 72.76M | 99.57M | 89.39M |
| Total Equity | 506.92M | 451.44M | 394.9M | 626.22M | 567.44M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 334.83M | 576.19M | 452.49M | 630.24M | 725.79M |
| Total Liabilities | 12.76M | 19.13M | 30.1M | 72.05M | 99.57M |
| Total Equity | 322.07M | 557.06M | 422.4M | 558.19M | 626.22M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -61.82M | -109.63M | -160.09M | -222.8M | -78.93M |
| Investing | 98.6M | 159.36M | 193.96M | 34.75M | 21.46M |
| Financing | -1.85M | -2.19M | -2.43M | 296.64M | -552k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -47.44M | -32.19M | -127.88M | -161.56M | -222.8M |
| Investing | -4.26M | -418.83M | 83.59M | -215.6M | 34.75M |
| Financing | 333.71M | 270.49M | 1.16M | 340.7M | 296.64M |
| Market Cap | 3.1B |
| Price to Earnings Ratio | -9.54 |
| Price to Sales Ratio | 569.8 |
| Price to Cash Ratio | 17.62 |
| Price to Book Ratio | 4.95 |
| Dividend Yield | - |
| Shares Outstanding | 74.09M |
| Average Volume (1 week) | 653.65k |
| Average Volume (1 Month) | 780.09k |
| 52 Week Change | 46.13% |
| 52 Week High | 53.92 |
| 52 Week Low | 18.00 |
| Spread (Intraday) | 12.34 (24.32%) |
| Company Name | SpringWorks Therapeutics Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.springworkstx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
